Overview

Price chart · mood · technical indicators

APYX

Apyx Medical Incstock Healthcare

Medical Devices

$2.85166.36%Current Market Mood:Neutral

Market Mood

Price Range (1Y)

$1.04$4.50

Current: $2.85

Idea: EMA

1Y Return

+78.4%

Sharpe 3Y

0.52

Market Comparison

vs Healthcare Sector & Medical Devices Industry

APYX

+166.36%

1Y Performance

Fundamentals

Updated daily after market close

P/E ratio—Forward 72.46

EPS (TTM)$-0.270.0% YoY

Profit margin-21.2%HEALTHCARE

Market cap$128.0MMicro cap

Wall Street coverage

$6.40median target· current $1.40 (+357.1%)5 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E: 72.46
PEG ratio: 0.59
P/B: 8.80
P/S (TTM): 2.42
EV/EBITDA: -5.33

Profitability & growth

ROE (TTM): -76.1%
Operating margin: 0.1%
Revenue growth YoY: 34.7%
Dividend yield: —
Beta: 1.54

Last earnings

Mar 10, 2026 · Estimate $-0.06 · Reported $-0.03

Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

50 articles · sorted by date

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Apyx Medical Inc

Company profile

Apyx Medical Corporation, an energy technology company, develops, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. The company is headquartered in Clearwater, Florida.

Classification

Sector: Healthcare
Industry: Medical Devices
Exchange: NASDAQ
Country: USA
Currency: USD

Company profile

HQ: 5115 ULMERTON ROAD, CLEARWATER, FL
Fiscal year end: December
Latest quarter: Dec 31, 2025

Market cap$128.0M

Shares outstanding$41.8M

52W high$4.50

52W low$1.04

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer

Overview

APYX

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC

Apyx Medical (APYX) Expected to Announce Earnings on Thursday

Apyx Medical Corporation (NASDAQ:APYX) Receives Consensus Rating of "Moderate Buy" from Analysts

Apyx Medical (NASDAQ:APYX) Lowered to Hold Rating by Wall Street Zen

Apyx Medical schedules May 7 earnings call before market open

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Apyx Medical (NASDAQ:APYX) Stock Rating Upgraded by Wall Street Zen

Roth MKM Maintains Apyx Medical(APYX.US) With Buy Rating, Maintains Target Price $6

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

If You Invested $1,000 in Apyx Medical Corporation (APYX)

APYX Earnings History & Surprises | EPS & Revenue Results | APYX MEDICAL CORP (NASDAQ:APYX)

Apyx Medical (APYX) SVP exercises stock options to acquire 37,000 shares

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating |

AYON launch and cost cuts shape Apyx Medical (NASDAQ: APYX) 2025

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating

Apyx Medical (NASDAQ: APYX) grows 2025 sales and sharply narrows loss

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating

Apyx Medical Calls AYON a “Game Changer” at Citizens Conference, Targets Profitability in 2025

Apyx Medical Corp Q4 And FY25 Revenue Improves; Lifts FY26 Revenue View By Approx. 9%-10%; Stock Up

Earnings Breakdown: Apyx Medical Q4

About Apyx Medical Inc

Classification

Company profile

APYX

Market Comparison

APYX Market Analysis

Overview

APYX

Market Comparison

Fundamentals

Wall Street coverage

Valuation

Profitability & growth

News & Sentiment

1,104,970 Shares in Apyx Medical Corporation $APYX Purchased by AIGH Capital Management LLC

Apyx Medical (APYX) Expected to Announce Earnings on Thursday

Apyx Medical Corporation (NASDAQ:APYX) Receives Consensus Rating of "Moderate Buy" from Analysts

Apyx Medical (NASDAQ:APYX) Lowered to Hold Rating by Wall Street Zen

Apyx Medical schedules May 7 earnings call before market open

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Apyx Medical (NASDAQ:APYX) Stock Rating Upgraded by Wall Street Zen

Roth MKM Maintains Apyx Medical(APYX.US) With Buy Rating, Maintains Target Price $6

Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"

If You Invested $1,000 in Apyx Medical Corporation (APYX)

APYX Earnings History & Surprises | EPS & Revenue Results | APYX MEDICAL CORP (NASDAQ:APYX)

Apyx Medical (APYX) SVP exercises stock options to acquire 37,000 shares

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating |

AYON launch and cost cuts shape Apyx Medical (NASDAQ: APYX) 2025

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating

Apyx Medical (NASDAQ: APYX) grows 2025 sales and sharply narrows loss

APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating

Apyx Medical Calls AYON a “Game Changer” at Citizens Conference, Targets Profitability in 2025

Apyx Medical Corp Q4 And FY25 Revenue Improves; Lifts FY26 Revenue View By Approx. 9%-10%; Stock Up

Earnings Breakdown: Apyx Medical Q4

About Apyx Medical Inc

Classification

Company profile

APYX

Market Comparison